Discovery - University of Dundee - Online Publications

Library & Learning Centre

PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65

PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65

Research output: Contribution to journalArticle

View graph of relations

Authors

  • Chandana Kondapalli
  • Agne Kazlauskaite
  • Ning Zhang
  • Helen I. Woodroof
  • David G. Campbell
  • Robert Gourlay
  • Lynn Burchell
  • Helen Walden
  • Thomas J. MacArtney
  • Maria Deak
  • Axel Knebel
  • Dario R. Alessi
  • Miratul M. K. Muqit (Lead / Corresponding author)

Research units

Info

Original languageEnglish
???articleNumber???120080
JournalOpen Biology
Journal publication date2012
Volume2
DOIs
StatePublished

Abstract

Missense mutations in PTEN-induced kinase 1 (PINK1) cause autosomalrecessive inherited Parkinson's disease (PD). We have exploited our recent discovery that recombinant insect PINK1 is catalytically active to test whether PINK1 directly phosphorylates 15 proteins encoded by PD-associated genes as well as proteins reported to bind PINK1. We have discovered that insect PINK1 efficiently phosphorylates only one of these proteins, namely the E3 ligase Parkin. We have mapped the phosphorylation site to a highly conserved residue within the Ubl domain of Parkin at Ser . We show that human PINK1 is specifically activated by mitochondrial membrane potential (? ?m) depolarization, enabling it to phosphorylate Parkin at Ser . We further show that phosphorylation of Parkin at Ser leads to marked activation of its E3 ligase activity that is prevented by mutation of Ser or inactivation of PINK1. We provide evidence that once activated, PINK1 autophosphorylates at several residues, including Thr257, which is accompanied by an electrophoretic mobility band-shift. These results provide the first evidence that PINK1 is activated following Dcm depolarization and suggest that PINK1 directly phosphorylates and activates Parkin. Our findings indicate that monitoring phosphorylation of Parkin at Ser and/or PINK1 at Thr257 represent the first biomarkers for examining activity of the PINK1-Parkin signalling pathway in vivo. Our findings also suggest that small molecule activators of Parkin that mimic the effect of PINK1 phosphorylation may confer therapeutic benefit for PD. © 2012 The Authors.

Documents

Library & Learning Centre

Contact | Accessibility | Policy